首页> 美国卫生研究院文献>Pulmonary Circulation >Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension
【2h】

Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension

机译:Takotsubo心肌病治疗肺动脉高压后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pulmonary arterial hypertension is a fatal disease. Intravenous prostanoids are often utilized for long-term management of patients. The therapy requires a significant commitment and change in lifestyle for both the patient and family. Takotsubo cardiomyopathy, transient apical ballooning syndrome, has been reported in association with emotional and physical stress. This case report describes a patient with pulmonary arterial hypertension who developed Takotsubo cardiomyopathy after treatment initiation with intravenous treprostinil. Over time, the syndrome resolved and the patient had return of normal left ventricular function. Takotsubo cardiomyopathy should be recognized as a potential, rare complication of therapy initiation due to the severity of the illness and the emotional stress of the disease.
机译:肺动脉高压是一种致命疾病。静脉前列腺素通常用于患者的长期治疗。该疗法需要患者和家人作出重大承诺并改变生活方式。据报道,Takotsubo心肌病是一过性的根尖球囊扩张综合征,与情绪和身体压力有关。该病例报告描述了患有肺动脉高压的患者,该患者在开始用静脉曲前列环素治疗后发展了Takotsubo心肌病。随着时间的流逝,综合征消失,患者的左心室功能恢复正常。由于疾病的严重程度和疾病的情感压力,Takotsubo心肌病应被认为是潜在的,罕见的开始治疗并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号